Compounder

Samantha McLemore

Net buying

Patient Capital Management, LLC — managed by Samantha McLemore; US equity positions disclosed quarterly via SEC 13F

Data as of 2026-03-31 (filed 2026-05-14) · Source: SEC EDGAR

Portfolio value$2.74B+6%)
Holdings40
Latest period2026-03-31
Top holdingRoyalty Pharma Plc
Portfolio overview

Patient Capital Management, LLC's most recent 13F filing, for the quarter ended 2026-03-31, reports 40 positions worth $2.74B. The top 5 holdings represent 28% of that value, a broadly diversified portfolio.

The single largest position is Royalty Pharma Plc at 6.4% of the portfolio, followed by Citigroup Inc at 5.9% and Alphabet Inc at 5.6%.

Against the prior quarter, Samantha McLemore opened 4 new positions, exited 4, added to 23, and trimmed 11. The largest new buy was Adobe Inc. The most notable sale was the full exit from Mattel Inc.

Across all 8 quarters on file, Royalty Pharma Plc has appeared in every filing, as has Citigroup Inc. Royalty Pharma Plc currently ranks first by value.

A 13F is filed roughly 45 days after quarter-end and covers only long positions in US-listed equities, so it is a lagging and partial view of the portfolio. Source: SEC EDGAR.

High-conviction
Holdings

Showing top 25 of 40 positions

Sources· SEC EDGAR 13F as of 2026-05-14

Stay Updated

Curated 13F moves and valuation insights, straight to your inbox.